IL17A and neoplasm: Similarly, in breast cancer, ZC3H12A inactivates IL-17 signaling to suppress tumor growth and metastasis [68] and exerts anti-proliferative effects by inducing G0/G1 cell cycle arrest in triple-negative breast cancer (TNBC) [69].